Here are five things to know:
1. The company warned hospitals to inspect 21 models of the devices for pieces of plastic packaging that could stick to the implants or devices.
2. Zimmer Biomet officials estimate one in 12,800 devices are affected, meaning around 60 of the 730,000 knee, hip and shoulder implants distributed.
3. The FDA labeled the recall as Class II because it won’t trigger severe or deadly reactions if the implant is placed in a patient.
4. The recall was officially announced last month.
5. The company reported a 9.1 percent increase in the quarterly dividend for the first quarter of 2016 and the board of directors authorized a new share repurchase program.
More articles on spine surgery:
5 thoughts on outcomes measurements for spinal trauma patients
10 spine, neurosurgeons on the move in January
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.